Michael S. Tanaka

Oncology
4501 X St
Sacramento, CA 95817

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Journal: Cancer treatment and research communications
Published: July 25, 2017
Showing 1-1 of 1

Last Updated: 09/26/2026